| Anemia in oncology practice: relation to diseases and their therapies F Tas, Y Eralp, M Basaran, B Sakar, S Alici, A Argon, G Bulutlar, ... American journal of clinical oncology 25 (4), 371-379, 2002 | 185 | 2002 |
| Colorectal cancer in young patients: characteristics and outcome S Alici, NF Aykan, B Sakar, G Bulutlar, E Kaytan, E Topuz The Tohoku journal of experimental medicine 199 (2), 85-93, 2003 | 129 | 2003 |
| The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients F Tas, Z Ustuner, G Can, Y Eralp, H Camlica, M Basaran, H Karagol, ... Acta oncologica 44 (2), 161-167, 2005 | 119 | 2005 |
| Timing of death from tumor recurrence after curative gastrectomy for gastric cancer B Sakar, H Karagol, M Gumus, M Basaran, E Kaytan, A Argon, Z Ustuner, ... American journal of clinical oncology 27 (2), 205-209, 2004 | 98 | 2004 |
| Skull base plasmacytoma in a patient with light chain myeloma Z Ustuner, M Basaran, T Kiris, B Bilgic, S Sencer, B Sakar, Y Dizdar, ... Skull base 13 (03), 167-172, 2003 | 59 | 2003 |
| Fourth versus eighth week surgery after neoadjuvant radiochemotherapy in T3-4/N0+ rectal cancer: Istanbul R-01 study S Saglam, D Bugra, EK Saglam, O Asoglu, E Balik, S Yamaner, ... Journal of gastrointestinal oncology 5 (1), 9, 2014 | 52 | 2014 |
| Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix Y Eralp, P Saip, B Sakar, S Kucucuk, A Aydiner, M Dincer, I Aslay, ... International Journal of Gynecologic Cancer 13 (4), 2003 | 50 | 2003 |
| Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy F Tas, S Karabulut, R Ciftci, F Sen, B Sakar, R Disci, D Duranyildiz Cancer chemotherapy and pharmacology 73, 1163-1171, 2014 | 49 | 2014 |
| Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancer E Topuz, D Derin, G Can, E Kürklü, S Çınar, F Aykan, A Çevikbaş, R Dişçi, ... Investigational New Drugs 26, 567-572, 2008 | 47 | 2008 |
| A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas M Basaran, ES Bavbek, S Saglam, L Eralp, B Sakar, AC Atalar, B Bilgic, ... Oncology 72 (3-4), 255-260, 2008 | 43 | 2008 |
| Ewing's sarcoma of the axial system in patients older than 15 years: dismal prognosis despite intensive multiagent chemotherapy and aggressive local treatment A Argon, M Basaran, F Yaman, Y Dizdar, B Sakar, H Camlica, SE Bavbek, ... Japanese Journal of Clinical Oncology 34 (11), 667-672, 2004 | 36 | 2004 |
| Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis B Sakar, Z Ustuner, H Karagol, G Aksu, H Camlica, NF Aykan American journal of clinical oncology 27 (5), 489-493, 2004 | 35 | 2004 |
| Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis G Aksu, M Fayda, B Sakar, Y Kapran International journal of gastrointestinal cancer 34, 73-77, 2003 | 32 | 2003 |
| Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study E Topuz, M Basaran, P Saip, A Aydiner, A Argon, B Sakar, F Tas, K Uygun, ... American journal of clinical oncology 25 (6), 619-624, 2002 | 31 | 2002 |
| Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy N Faruk Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, ... Medical Oncology 30, 1-6, 2013 | 26 | 2013 |
| A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer M Basaran, SE Bavbek, I Güllü, F Demirelli, B Sakar, N Tenekeci, M Altun, ... Journal of chemotherapy 14 (2), 207-213, 2002 | 25 | 2002 |
| Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC) S Keskin, I Yıldız, F Sen, F Aydogan, L Kilic, M Ekenel, S Saglam, B Sakar, ... Clinical and Translational Oncology 15, 403-408, 2013 | 16 | 2013 |
| Tamoxifen and gallstone formation in postmenopausal breast cancer patients: retrospective cohort study ML Akin, H Uluutku, C Erenoglu, A Karadag, BM Gulluoglu, B Sakar, ... World journal of surgery 27 (4), 395-399, 2003 | 16 | 2003 |
| Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: Can they be used as biomarkers? K Erturk, D Tastekin, E Bilgin, M Serilmez, HU Bozbey, B Sakar Biomedicine & Pharmacotherapy 77, 86-91, 2016 | 15 | 2016 |
| Prognostic significance of the metastatic lymph node ratio for survival in colon cancer S Tuna, M Dalkilic Calis, B Sakar, F Aykan, H Camlica, E Topuz J BUON 16 (3), 478-485, 2011 | 12 | 2011 |
